Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

The Interventional Pharmacoeconomic Toolbox Panel Discussion

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Welcome and Introduction to Vi3C

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Nov
13
Today In Oncology
FDA Approves Ziftomenib for NMP1-Positive AML
Ezabenlimab, Induction Chemotherapy, and Adaptive Chemoradiotherapy in Stage III Squamous Cell Anal Carcinoma
Transfusion Access Prioritized Over Routine Hospice Services Among Patients With Blood Cancers
Advanced Epithelial Ovarian Cancer First-Line PARP Inhibitor Maintenance Therapy and Survival
Underlying Mechanisms of Chemoresistance in AML
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo